Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma by Carroll, Thomas M., Chadwick, Joseph A., Owen, Richard P., White, Michael J., Kaplinsky, Joseph, Peneva, Iliana, Frangou, Anna, Xie, Phil F., Chang, Jaeho, Roth, Andrew, Amess, Bob, James, Sabrina A., Rei, Margarida, Fuchs, Hannah S., McCann, Katy J., Omiyale, Ayo O., Jacobs, Brittany-Amber, Lord, Simon R., Norris-Bulpitt, Stewart, Dobbie, Sam T., Griffiths, Lucinda, Ramirez, Kristen Aufiero, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph R., Van den Eynde, Benoit J., Karydis, Ioannis, Schuster-Böckler, Benjamin, Middleton, Mark R., Lu, Xin, Ahern, David, Amess, Bob, Ramirez, Kristen Aufiero, Berridge, Georgina, Carroll, Thomas M., Chadwick, Joseph A., Chang, Jaeho, Cheng, Jingfei, Dobbie, Sam T., Drozdz, Magdalena, Fischer, Roman, Frangou, Anna, Fuchs, Hannah S., Griffiths, Lucinda, Inoue, Masato, Jacobs, Brittany-Amber, James, Sabrina A., Kaplinsky, Joseph, Karydis, Ioannis, Kessler, Benedikt M., Lord, Simon R., Lou, Hantao, Lu, Xin, Macri, Mary J., McCann, Katy J., McGregor, Naomi, Middleton, Mark R., Norris-Bulpitt, Stewart, Omiyale, Ayo O., Owen, Richard P., Peneva, Iliana, Phetsouphanh, Chansavath, Rei, Margarida, Ricciardi, Toni, Roth, Andrew, Puig, Carlos Ruiz, Ryan, Aileen, Schuster-Böckler, Benjamin, Siejka-Zielińska, Paulina, Song, Chunxiao, Tomkova, Marketa, Van den Eynde, Benoit J., Velikova, Gergana, Venhaus, Ralph R., White, Michael J., Xie, Phil F.

Get full text

Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer by Hall, Peter E., Ready, Neal, Johnston, Amanda, Bomalaski, John S., Venhaus, Ralph R., Sheaff, Michael, Krug, Lee, Szlosarek, Peter W.

Get full text

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant by Adams, Sylvia, O'Neill, David W, Nonaka, Daisuke, Hardin, Elizabeth, Chiriboga, Luis, Siu, Kimberly, Cruz, Crystal M, Angiulli, Angelica, Angiulli, Francesca, Ritter, Erika, Holman, Rose Marie, Shapiro, Richard L, Berman, Russell S, Berner, Natalie, Shao, Yongzhao, Manches, Olivier, Pan, Linda, Venhaus, Ralph R, Hoffman, Eric W, Jungbluth, Achim, Gnjatic, Sacha, Old, Lloyd, Pavlick, Anna C, Bhardwaj, Nina

Get full text

NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus by Chen, Ji‐Li, Dawoodji, Amina, Tarlton, Andrea, Gnjatic, Sacha, Tajar, Abdelouahid, Karydis, Ioannis, Browning, Judy, Pratap, Sarah, Verfaille, Christian, Venhaus, Ralph R., Pan, Linda, Altman, Douglas G., Cebon, Jonathan S., Old, Lloyd L., Nathan, Paul, Ottensmeier, Christian, Middleton, Mark, Cerundolo, Vincenzo

Get full text

Abstract 1247: Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma by Carroll, Thomas M., Chadwick, Joseph A., Owen, Richard P., White, Michael J., Kaplinsky, Joseph, Peneva, Iliana, Frangou, Anna, Chang, Jaeho, Xie, Phil F., Roth, Andrew, Amess, Bob, Lou, Hantao, McCann, Katy J., Berridge, Georgina, Fischer, Roman, Phetsouphanh, Chansavath, Omiyale, Ayo O., Jacobs, Brittany-Amber, Ahern, David, Lord, Simon R., Norris-Bulpitt, Stewart, Dobbie, Sam T., Griffiths, Lucinda, Ramirez, Kristen Aufiero, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph R., Van den Eynde, Benoit J., Karydis, Ioannis, Kessler, Benedikt M., Schuster-Böckler, Benjamin, Middleton, Mark R., Lu, Xin

Get full text

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using Toll-like receptor 7 agonist imiquimod as vaccine adjuvant by Adams, Sylvia, O'Neill, David W., Nonaka, Daisuke, Hardin, Elizabeth, Chiriboga, Luis, Siu, Kimberly, Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Ritter, Erika, Holman, Rose Marie, Shapiro, Richard L., Berman, Russell S., Berner, Natalie, Shao, Yongzhao, Manches, Olivier, Pan, Linda, Venhaus, Ralph R., Hoffman, Eric W., Jungbluth, Achim, Gnjatic, Sacha, Old, Lloyd, Pavlick, Anna C., Bhardwaj, Nina

Get full text

Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients by Sabbatini, Paul, Tsuji, Takemasa, Ferran, Luis, Ritter, Erika, Sedrak, Christine, Tuballes, Kevin, Jungbluth, Achim A, Ritter, Gerd, Aghajanian, Carol, Bell-McGuinn, Katherine, Hensley, Martee L, Konner, Jason, Tew, William, Spriggs, David R, Hoffman, Eric W, Venhaus, Ralph, Pan, Linda, Salazar, Andres M, Diefenbach, Catherine Magid, Old, Lloyd J, Gnjatic, Sacha

Get full text

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma by Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan, Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael P N, Hersey, Peter, Evans, T R Jeffry, Ottensmeier, Christian Hermann, Marsden, Jeremy, Dalgleish, Angus G, Corrie, Pippa G, Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M, Endo-Munoz, Liliana, Tutuka, Candani S A, Venhaus, Ralph, Old, Lloyd J, Haack, Dennis, Maraskovsky, Eugene, Behren, Andreas, Chen, Weisan

Get full text

Phase I Trial of Overlapping Long Peptides from a Tumor SelfAntigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients by SABBATINI, Paul, TSUJI, Takemasa, HENSLEY, Martee L, KONNER, Jason, TEW, William, SPRIGGS, David R, HOFFMAN, Eric W, VENHAUS, Ralph, PAN, Linda, SALAZAR, Andres M, MAGID DIEFENBACH, Catherine, OLD, Lloyd J, FERRAN, Luis, GNJATIC, Sacha, RITTER, Erika, SEDRAK, Christine, TUBALLES, Kevin, JUNGBLUTH, Achim A, RITTER, Gerd, AGHAJANIAN, Carol, BELL-MCGUINN, Katherine

Get full text